UK - Longbow and Capital Fund invest £1m in Domainex
Longbow Capital and The Capital Fund have invested ТЃ1m in biopharmaceutical company Domainex.
Longbow invested £790,000 and The Capital Fund invested £250,000. Domainex specialises in the provision of structural biology and chemistry services to pharmaceutical and biotechnology funds. The company is a spin-out from University College London.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








